CXCL11 promotes self-renewal and tumorigenicity of α2δ1+ liver tumor-initiating cells through CXCR3/ERK1/2 signaling

被引:44
作者
Zhang, Yuan [1 ]
Zhao, Wei [1 ]
Li, Sheng [1 ]
Lv, Mengzhu [1 ]
Yang, Xiaodan [1 ]
Li, Meng [1 ]
Zhang, Zhiqian [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Cell Biol, Minist Educ, Key Lab Carcinogenesis & Translat Res, 52 Fucheng Rd, Beijing 100142, Peoples R China
基金
中国国家自然科学基金;
关键词
CXCL11; Hepatocellular carcinoma; Tumor-initiating cell; CXCR3; ERK1/2; CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC TARGET; CHRONIC HEPATITIS; I-TAC; CHEMOKINE; INTERLEUKIN-6; SURVIVAL; BINDING;
D O I
10.1016/j.canlet.2019.02.016
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tumor-initiating cells (TICs), which are responsible for sustaining tumor growth and recurrence, rely on several regulatory factors. However, the mechanism of inflammation-related molecules in the acquisition and maintenance of TIC properties in hepatocellular carcinoma (HCC) remains elusive. We previously demonstrated that the voltage-gated calcium channel alpha 2 delta 1 subunit is a functional surface marker of HCC TICs. Here, we found that the expression of an inflammation-related molecule C-X-C motif chemokine 11 (CXCL11) was significantly upregulated in alpha 2 delta 1 HCC TICs and that CXCL11 induced the expression of stem cell-related genes, such as BMI1, NANOG, MDR1, ABCG2, and CACNA2D1. Furthermore, CXCL11 could promote the acquisition and maintenance of self-renewal, tumorigenic, and chemoresistance properties of alpha 2 delta 1(+) HCC TICs by activating the extracellular signal-regulated kinase (ERK1/2) through its affinity receptor CXCR3. Collectively, our results suggest that CXCL11 may positively regulate the stemness of alpha 2 delta 1(+) HCC TICs via ERK1/2 activation through an autocrine signaling pathway.
引用
收藏
页码:163 / 171
页数:9
相关论文
共 32 条
[1]   Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt [J].
Berres, Marie-Luise ;
Lehmann, Jennifer ;
Jansen, Christian ;
Goertzen, Jan ;
Meyer, Carsten ;
Thomas, Daniel ;
Zimmermann, Henning W. ;
Kroy, Daniela ;
Schumacher, Fabienne ;
Strassburg, Christian P. ;
Sauerbruch, Tilman ;
Trautwein, Christian ;
Wasmuth, Hermann E. ;
Trebicka, Jonel .
LIVER INTERNATIONAL, 2016, 36 (03) :386-394
[2]   Turning Hepatic Cancer Stem Cells Inside Out - A Deeper Understanding through Multiple Perspectives [J].
Chan, Lok-Hei ;
Luk, Steve T. ;
Ma, Stephanie .
MOLECULES AND CELLS, 2015, 38 (03) :202-209
[3]   The cancer stem cell: premises, promises and challenges [J].
Clevers, Hans .
NATURE MEDICINE, 2011, 17 (03) :313-319
[4]   Interferon-inducible T cell alpha chemoattractant (I-TAC): A novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3 [J].
Cole, KE ;
Strick, CA ;
Paradis, TJ ;
Ogborne, KT ;
Loetscher, M ;
Gladue, RP ;
Lin, W ;
Boyd, JG ;
Moser, B ;
Wood, DE ;
Sahagan, BG ;
Neote, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (12) :2009-2021
[5]   Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma [J].
Fan, Qing-Min ;
Jing, Ying-Ying ;
Yu, Guo-Feng ;
Kou, Xing-Rui ;
Ye, Fei ;
Gao, Lu ;
Li, Rong ;
Zhao, Qiu-Dong ;
Yang, Yang ;
Lu, Zheng-Hua ;
Wei, Li-Xin .
CANCER LETTERS, 2014, 352 (02) :160-168
[6]   MicroRNA-144 mediates chronic inflammation and tumorigenesis in colorectal cancer progression via regulating C-X-C motif chemokine ligand 11 [J].
Han, Bin ;
Feng, Dan ;
Yu, Xin ;
Liu, Yuanqi ;
Yang, Ming ;
Luo, Fei ;
Zhou, Liming ;
Liu, Fu .
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (03) :1935-1943
[7]   PBX3 is targeted by multiple miRNAs and is essential for liver tumour-initiating cells [J].
Han, Haibo ;
Du, Yantao ;
Zhao, Wei ;
Li, Sheng ;
Chen, Dongji ;
Zhang, Jing ;
Liu, Jiang ;
Suo, Zhenhe ;
Bian, Xiuwu ;
Xing, Baocai ;
Zhang, Zhiqian .
NATURE COMMUNICATIONS, 2015, 6
[8]   CD13 is a therapeutic target in human liver cancer stem cells [J].
Haraguchi, Naotsugu ;
Ishii, Hideshi ;
Mimori, Koshi ;
Tanaka, Fumiaki ;
Ohkuma, Masahisa ;
Kim, Ho Min ;
Akita, Hirofumi ;
Takiuchi, Daisuke ;
Hatano, Hisanori ;
Nagano, Hiroaki ;
Barnard, Graham F. ;
Doki, Yuichiro ;
Mori, Masaki .
JOURNAL OF CLINICAL INVESTIGATION, 2010, 120 (09) :3326-3339
[9]   Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling [J].
He, Guobin ;
Dhar, Debanjan ;
Nakagawa, Hayato ;
Font-Burgada, Joan ;
Ogata, Hisanobu ;
Jiang, Yuhong ;
Shalapour, Shabnam ;
Seki, Ekihiro ;
Yost, Shawn E. ;
Jepsen, Kristen ;
Frazer, Kelly A. ;
Harismendy, Olivier ;
Hatziapostolou, Maria ;
Iliopoulos, Dimitrios ;
Suetsugu, Atsushi ;
Hoffman, Robert M. ;
Tateishi, Ryosuke ;
Koike, Kazuhiko ;
Karin, Michael .
CELL, 2013, 155 (02) :384-396
[10]   Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation [J].
Helbig, KJ ;
Ruszkiewicz, A ;
Semendric, L ;
Harley, HA ;
McColl, SR ;
Beard, MR .
HEPATOLOGY, 2004, 39 (05) :1220-1229